What is Syndax Pharmaceuticals's capex?

Syndax Pharmaceuticals (SNDX) reported capex of $46.75K in Q4 2025.

What is the long-term trend for Syndax Pharmaceuticals's capex?

Over 4 years (2021 to 2025), Syndax Pharmaceuticals's capex has grown at a 9.7% compound annual growth rate (CAGR), from $129K to $187K.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Syndax Pharmaceuticals SNDX CapEx

Discontinued — last reported Q4 '25

CapEx at other companies

BiogenBIIB

$51.2M+38.0%

AbbVieABBV

$265M+12.8%

Viridian Therapeutics, Inc.VRDN

$23K-73.3%

Nuvation BioNUVB

$48K-33.3%

ImmunomeIMNM

$3M-18.1%

IncyteINCY

——

Other financials

Income statement

See full

Revenue$64.9M+224%

Operating income-$34.2M+59.2%

Net income-$42.7M+49.7%

EPS (diluted)-$0.48+51.0%

Balance sheet

See full

Cash & equivalents$130.9M-15.0%

Total debt$350.5M+4.2%

Total equity$41.6M-80.6%

Total assets$472.7M-26.2%

Cash flow

See full

Operating cash flow-$50.3M+47.1%

Free cash flow-$80.8M-17.6%

Valuation

See full

Market cap$1.74B+95.0%

Enterprise value$1.96B+84.0%

P/S8×-12.4×

Profitability

See full

Operating margin-102.8%-47.8pp

Net margin-111.9%-51.5pp

FCF margin-187.2%-85.4pp

Returns & leverage

See full

Return on equity-189.5%-8,509pp

Debt / equity8.4×+6.9×

Current ratio5.5×-0.3×

Where this comes from

Reported directly by Syndax Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Syndax Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Syndax Pharmaceuticals's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Syndax Pharmaceuticals's capex?: Syndax Pharmaceuticals (SNDX) reported capex of $46.75K in Q4 2025.
What is the long-term trend for Syndax Pharmaceuticals's capex?: Over 4 years (2021 to 2025), Syndax Pharmaceuticals's capex has grown at a 9.7% compound annual growth rate (CAGR), from $129K to $187K.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.